1. Home
  2. ZBAI vs CMND Comparison

ZBAI vs CMND Comparison

Compare ZBAI & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZBAI
  • CMND
  • Stock Information
  • Founded
  • ZBAI 2015
  • CMND 2017
  • Country
  • ZBAI United States
  • CMND Canada
  • Employees
  • ZBAI N/A
  • CMND N/A
  • Industry
  • ZBAI Professional Services
  • CMND Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZBAI Consumer Discretionary
  • CMND Health Care
  • Exchange
  • ZBAI Nasdaq
  • CMND Nasdaq
  • Market Cap
  • ZBAI 6.5M
  • CMND 5.3M
  • IPO Year
  • ZBAI N/A
  • CMND N/A
  • Fundamental
  • Price
  • ZBAI $5.75
  • CMND $1.03
  • Analyst Decision
  • ZBAI
  • CMND
  • Analyst Count
  • ZBAI 0
  • CMND 0
  • Target Price
  • ZBAI N/A
  • CMND N/A
  • AVG Volume (30 Days)
  • ZBAI 35.0K
  • CMND 309.3K
  • Earning Date
  • ZBAI 06-06-2025
  • CMND 09-15-2025
  • Dividend Yield
  • ZBAI N/A
  • CMND N/A
  • EPS Growth
  • ZBAI N/A
  • CMND N/A
  • EPS
  • ZBAI N/A
  • CMND N/A
  • Revenue
  • ZBAI $720,000.00
  • CMND N/A
  • Revenue This Year
  • ZBAI N/A
  • CMND N/A
  • Revenue Next Year
  • ZBAI N/A
  • CMND N/A
  • P/E Ratio
  • ZBAI N/A
  • CMND N/A
  • Revenue Growth
  • ZBAI 44.00
  • CMND N/A
  • 52 Week Low
  • ZBAI $4.93
  • CMND $0.80
  • 52 Week High
  • ZBAI $45.00
  • CMND $2.18
  • Technical
  • Relative Strength Index (RSI)
  • ZBAI N/A
  • CMND 54.72
  • Support Level
  • ZBAI N/A
  • CMND $0.95
  • Resistance Level
  • ZBAI N/A
  • CMND $1.05
  • Average True Range (ATR)
  • ZBAI 0.00
  • CMND 0.05
  • MACD
  • ZBAI 0.00
  • CMND 0.00
  • Stochastic Oscillator
  • ZBAI 0.00
  • CMND 80.00

About ZBAI ATIF Holdings Limited Ordinary Shares

ATIF Holdings Ltd is a consulting company. It provides financial and advisory services to small and medium-sized enterprises and also to individual customers and families. The firm also offers Pre-IPO's, and Post-IPO's services. It operates in one operating segment which is the consulting service business. It generates the majority of its revenue from the USA.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Share on Social Networks: